Dr. Mark Douglas Zukunft, MD

Dr. Zukunft practices at Walnut Creek Medical Center in Walnut Creek, California, part of Kaiser Permanente.

Dr. Zukunft's NPI, 1437563855, was assigned on June 13, 2014. Dr. Zukunft graduated from Loyola University Chicago Stritch School of Medicine in 2013. Dr. Zukunft holds California license A149737.

Dr. Zukunft's primary practice is Walnut Creek Medical Center, at 1425 S Main Street, Walnut Creek, CA 94596 in Contra Costa County. The practice phone is (925) 295-4000.

Dr. Zukunft's primary practice is Walnut Creek Medical Center in Walnut Creek, California, part of Kaiser Permanente. Dr. Zukunft is also affiliated with San Jose Medical Center. The medical group on file is The Permanente Medical Group, Inc.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zukunft practices, 2 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Zukunft's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Zukunft is board certified in emergency medicine by the American Board of Emergency Medicine. Dmand AI has Dr. Zukunft's licenses on file in 4 states: California, Indiana, Illinois and Wisconsin.

CMS data shows 20 Medicare services from Dr. Zukunft across 1 procedure code in 2024, for 27 Medicare patients. Medicare paid $1,139 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 27 Medicare patients who saw Dr. Zukunft in 2024. 56% of them have high blood pressure, and 48% have high cholesterol. 59% are also on Medicaid. Their average risk score is 1.87, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Zukunft's median patient age at 44, with 62% women.

In 2024, Dr. Zukunft wrote 567 Medicare Part D claims for 348 patients. 94% of them were for generic drugs. CMS names the drug for 359 of them, across 14 drugs with 11 or more claims each, at $3,863 in total drug cost. In 2023, CMS named 160 claims across 7 drugs.

Dr. Zukunft accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dr. Zukunft graduated from Loyola University Chicago Stritch School of Medicine in 2013.

Dr. Zukunft is in network with 2 carriers, including Kaiser Permanente and CMS Medicare. EPO plans come from the most carriers, 1. Check the plan with the practice before a visit.